Knöps, Eva http://orcid.org/0000-0001-9208-7470
Spuls, Phyllis http://orcid.org/0000-0002-6035-2863
Duijnhoven, Ruben http://orcid.org/0000-0002-4784-4396
Dijkgraaf, Marcel
van Barreveld, Marit
Arents, Bernd http://orcid.org/0000-0001-6884-8014
van Enst, Annefloor
Garritsen, Floor
Merkus, Maruschka
Middelkamp-Hup, Pina
Musters, Annelie
Bosma, Angela
Hyseni, Ariënna
Dijkstra, Jitske
Hijnen, Dirk Jan
Gerbens, Louise http://orcid.org/0000-0002-5244-5058
Funding for this research was provided by:
ZonMw (10330032010008)
Stichting Fonds Onderzoek Huidziekten (202304-01)
Article History
Received: 11 March 2024
Accepted: 11 July 2024
First Online: 16 July 2024
Declarations
:
: The MREC of the Academic Medical Center Amsterdam approved of this trial, reference number 2022.0675 NL81882.018.22. Written, informed consent to participate will be obtained from all participants.
: By signing the informed consent form, all participants consent to the publication of their (pseudonymized) data. We are willing to provide a model consent form on request.
: PS has received departmental independent research grants for the TREAT NL registry from Pharma since December 2019, is the Chief Investigator (CI) of the systemic and phototherapy atopic eczema registry (TREAT NL) for adults and children, and is involved in performing clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of, e.g., psoriasis and atopic dermatitis, for which financial compensation is paid to the department/hospital. She was involved in the development of one of the HOME core outcome instruments (recap of atopic eczema (RECAP)), and in the development of the Outcome Measures for VAscular Malformations (OVAMA) questionnaire for vascular malformations.FG is on the advisory board of Abbvie and LEO pharma, organized a conference in association with Abbvie, and was a speaker at conferences for Abbvie, Sanofi, and Novartis.PMH received departmental independent research grants for TREAT NL registry from Pharma since December 2019 for the TREAT NL registry and is an investigator of the systemic and phototherapy atopic eczema registry (TREAT NL) for adults and children. She received a departmental independent research grant from the BIOMAP project and is part of the BIOMAP consortium. She is on the Dutch advisory board of Sanofi.DH is or has been a consultant and/or investigator for Abbvie, Almirall, AstraZeneca, Galderma, Janssen, LEO pharma, Lilly, Novartis, Pfizer, Sanofi, and UCB.LG is one of the main investigators of the TREatment of ATopic eczema (TREAT) NL registry, which has received departmental independent research grants from pharmaceutical industries since December 2019.EK, RD, MD, MB, BA, AE, MM, AM, AB, AH, and JD declare that they have no competing interests.